Anti-Tumor Effects of Low Dose Zoledronate on Lung Cancer-Induced Spine Metastasis

Zoledronate (Zol) is an anti-resorptive/tumoral agent used for the treatment of many cancers including spinal bone metastasis. High systemic administration of a single dose is now the standard clinical care, yet it has been associated with several side effects. Here, we aimed to evaluate the effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Akoury, Elie, Ramirez Garcia Luna, Ana Sofia, Ahangar, Pouyan, Gao, Xiaoya, Zolotarov, Pylyp, Weber, Michael H., Rosenzweig, Derek H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722631/
https://www.ncbi.nlm.nih.gov/pubmed/31416169
http://dx.doi.org/10.3390/jcm8081212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722631/
https://www.ncbi.nlm.nih.gov/pubmed/31416169
http://dx.doi.org/10.3390/jcm8081212

Ejemplares similares